Filter By
- Behavioral Health Services Division (BHSD)
- Child Support Services Division (CSSD)
- Developmental Disabilities Services Division (DDSD)
- (-) Division of Health Improvement (DHI)
- Health Care Coverage Innovations (HCCI)
- Heath Care Affordability Bureau
- Income Support Division (ISD)
- (-) Medical Assistance Division (MAD)
- Office of Fair Hearings (OFH)
- Office of Inspector General (OIG)
- State Health Benefits (SHB)
- Agency-Based Community Benefit (ABCB)
- Beneficiary Advisory Council (BAC)
- Employee Abuse Registry (EAR)
- Health Care Consolidation Oversight Act
- Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID)
- Justice-involved Utilization of State Transitioned Healthcare (JUST Health)
- New Mexico Medicaid Estate Recovery Program
- Ordering, Referring, Prescribing Provider (ORP)
- Rural Health Care Delivery Fund
- Turquoise Care
For three years following your transaction, you’ll submit yearly updates on financial performance, service volumes, community benefit activities, and any material changes—using the format HCA provides. You can fill out and submit the report form HERE. You will also need to include THIS FORM in your submission.
You can fill out the annual report form HERE. You will also need to fill out and inlcude THIS FORM in the submission.
Under the Health Care Consolidation Oversight Act, HCA may impose administrative fines on hospitals or transaction parties that knowingly violate filing requirements, proceed with a transaction without approval, or fail to comply with conditions. Fines are assessed on a per‑bed or per‑member basis (as specified in the administrative rules) and revenues are directed to the New Mexico School Fund.
You can find a full list of definitions of terms contained in the act HERE.
Yes. The Health Care Consolidation Oversight Act includes safeguards for individuals who report improper or undisclosed transactions. Whistleblowers may submit information confidentially to the HCA and are protected from retaliation. Any fine revenue collected from violations stemming from a whistleblower report also supports the School Fund.
If you are an ICF/IID provider, you can find the guide to completing the Level of Care MAD 378 abstract here: Admission Criteria.
You can access the current abstract by visiting the New Mexico Medicaid Portal website and navigating to providers section, selecting “view” under public information for the MAD 378 under HSC/MAD Forms.
For billing issues concerning denied claims, please contact the ICF/IID Program Coordinator with the Transaction Control Number (TCN). The IFor billing issues concerning denied claims, please first contact Conduent. Should you need further assistance please notify the ICF/IID Program Coordinator with the Transaction Control Number (TCN). The ICF/IID Program Coordinator will research the claim and assist with troubleshooting the errors.
For information and instructions on how to apply for a health facility license, please visit the Division of Health Improvement, Health Facility Licensing and Certification Program Operations Bureau page at: Programs Operations Bureau
Effective October 1, 2026, all ordering, referring, or prescribing providers must be individually enrolled in Medicaid in order for the rendering provider to be reimbursed.
Yes. All licensed behavioral health clinicians referring, ordering or prescribing services must enroll individually.
Yes. Hospital-employed or contracted clinicians who refer, order or prescribe Medicaid services must be individually enrolled.
Yes. Referring, ordering or prescribing providers contracted by Indian Health Services or a Tribal 648 must be enrolled consistent with federal and state requirements.
Yes, federal regulations require state Medicaid programs to enroll and screen providers who refer, order, or prescribe services to Medicaid members. This policy ensures compliance with those requirements.
Yes. MCO claims are subject to the same enrollment requirement. MCOs will deny claims for services rendered by non-enrolled providers effective October 1, 2026.
Yes. Even if claims are submitted under a group NPI or facility billing number, each individual referring, ordering or prescribing provider must be separately enrolled.
Yes. Individual clinicians referring, ordering or prescribing services within FQHCs and RHCs must be enrolled.
Referring, ordering and prescribing providers must enroll as a Medicaid provider. If a provider refuses to enroll, claims may be recouped. Prescriptions ordered by unenrolled pharmacists will be denied at the point of sale and members could be unable to receive needed medications.
Providers must submit an individual enrollment application through the Medicaid provider enrollment portal on YesNM.gov. Required documentation may include:
• Active NPI
• Professional license
• Disclosure information
• Screening documentation (as applicable)
Detailed instructions are available on YesNM.gov. To create a YESNM.gov account follow these
instructions.
Processing times vary depending on application completeness and required screening level. Providers are strongly encouraged to apply early to avoid payment delays
Group practices should review their roster against Medicaid enrollment records and contact Provider Enrollment for assistance at 800-299-7304 or nm.providers@hca.nm.gov.
Yes. HCA requires any participating pharmacy (on-site or community-based) to enroll and bill as a Medicaid pharmacy (separate from the medical provider) and to follow billing and claims processes, including all real-time or batched billing/claims requirements and prior authorization (PA) requirements (if applicable), that match current fee-for-service (FFS) processes.
Carceral facilities can bill for medications as medical claims when the medications are provided by the medical provider rather than dispensed directly from the pharmacy. For example, if a CDC purchases stock medications for Medication Assisted Treatment (MAT) and a qualified provider administers the treatment, the medications and any applicable services (e.g., evaluation or counseling) should be billed as a medical claim.
Facility staff may not transfer bulk medications into individual packages that do not meet state and federal prescribing standards (e.g., pill envelopes) for individuals to utilize upon release. Only medications that are labeled for a specific patient and fulfilled by a licensed pharmacist (including through a licensed onsite pharmacy) according to state and federal prescribing standards meet the medications-in-hand requirement.
No. Medicaid should only be billed for the portion of the bulk medication that is provided to the Medicaid member.
No. Medications must follow the Medicaid formulary, as identified by HCA’s preferred drug list (PDL). While updates to the PDL will be made on a regular basis, Medicaid-enrolled pharmacies should be up to date on covered drugs.
Yes. pharmacy providers are required to submit claims through the point-of-sale system. The point-of-sale system provides relevant drug utilization information that the pharmacist must consider before dispensing a drug. Pharmacies must follow the NM FFS Payer Sheet. The BIN for JUST Health Plus members is 028165, and pharmacy software systems must be updated accordingly so that patient profiles can reflect the new BIN. Additionally, pharmacies must have POS equipment capable of billing D.0 transactions to ensure claims can be received, processed, and sent for payment in the Turquoise Care System.
Yes. Carceral facilities with 340B-acquired medications must identify 340B participation and pricing on claims by using modifiers “UD” or “08” when billing Medicaid for the applicable medications. Please refer to Provider Supplement 20-04 for further instructions on billing for 340B-acquired medications.
HCA expects the ordering provider to determine clinical appropriateness of a new prescription. Providers have the option of overriding a “Fill too Soon” rejection. If utilization information indicates that the member has an adequate supply of the medication or that the quantity being dispensed is excessive, the pharmacist is responsible for resolving the issue by seeking an authorization to dispense the drug, if necessary.
The requirement is to provide up to a 30-day supply of the medications in-hand, as clinically appropriate except as outlined below. HCA expects prescribers to use their clinical judgement when determining the appropriate amount of medication to provide upon release.
Facilities are expected to provide medications in-hand upon release for individuals with stays longer than 48 hours, and who have been clinically evaluated and prescribed a medication.